Migraines and chronic daily headaches can have a debilitating effect on day-to-day life. By using magnetic resonance imaging (MRI) it has been found that iron accumulation in the brain has been correlated with both the duration of illness and the frequency of attacks.
Migraines and chronic daily headaches can have a debilitating effect on day-to-day life. By using magnetic resonance imaging (MRI) it has been found that iron accumulation in the brain has been correlated with both the duration of illness and the frequency of attacks.
A group of scientists have now carried out an experiment to measure the relationship between iron deposition in basal ganglia and pain regulatory nuclei in both neurologically healthy control volunteers and in patients with differing migraine subtypes.1 The team hoped to evaluate the tradeoff between sensitivity and specificity in T2 imaging of patients with migraine, and found that only T2 imaging in the globus pallidus was able to distinguish between episodic and chronic migraine, which suggests that this technique may be the most appropriate to assess migraine frequency. Patients with medication overuse headache (MOH) did not demonstrate T2’ shortening. As iron accumulation should cause shortening of both T2 and T2’ it was concluded that something other than increased iron deposition could be playing a role in MOH.
1. S.E. Jones et al., Headache: The Journal of Head and Face Pain, 52(2), 236–243 (2012).
This story originally appeared in The Column. Click here to view that issue.
AI and GenAI Applications to Help Optimize Purification and Yield of Antibodies From Plasma
October 31st 2024Deriving antibodies from plasma products involves several steps, typically starting from the collection of plasma and ending with the purification of the desired antibodies. These are: plasma collection; plasma pooling; fractionation; antibody purification; concentration and formulation; quality control; and packaging and storage. This process results in a purified antibody product that can be used for therapeutic purposes, diagnostic tests, or research. Each step is critical to ensure the safety, efficacy, and quality of the final product. Applications of AI/GenAI in many of these steps can significantly help in the optimization of purification and yield of the desired antibodies. Some specific use-cases are: selecting and optimizing plasma units for optimized plasma pooling; GenAI solution for enterprise search on internal knowledge portal; analysing and optimizing production batch profitability, inventory, yields; monitoring production batch key performance indicators for outlier identification; monitoring production equipment to predict maintenance events; and reducing quality control laboratory testing turnaround time.
2024 EAS Awardees Showcase Innovative Research in Analytical Science
November 20th 2024Scientists from the Massachusetts Institute of Technology, the University of Washington, and other leading institutions took the stage at the Eastern Analytical Symposium to accept awards and share insights into their research.